Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New Two-Pronged cancer drug enters key Dose-Finding trial
Disease control Recruiting nowThis study aims to find the best dose of a new drug called ivonescimab when used with standard chemotherapy for people newly diagnosed with extensive-stage small cell lung cancer. About 60 participants will receive one of two doses of ivonescimab along with carboplatin and etopos…
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Apr 04, 2026 03:21 UTC
-
Real-World lung cancer treatment study seeks to uncover which standard regimen works best
Disease control Recruiting nowThis study aims to collect information from routine medical practice to better understand the safety and effectiveness of two standard treatment options for advanced lung cancer with a specific genetic change (EGFR mutation). It will observe about 538 patients who are already rec…
Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Mar 10, 2026 12:52 UTC